Clinical Trial Update: Safety and Efficacy of SCH 503034 in Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03523) [Phase 2]

View source ↗

Summary

Phase 2 trial results for SCH 503034 in previously untreated genotype 1 chronic hepatitis C show safety and efficacy outcomes, with the study completed and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• SCH 503034

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED | Results posted: 2011-06-15